HAL Allergy B.V.

1 trials Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

6 Countries active

19 Unique IMPs

100% Results reported

Phase III

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

ARTEMISIA VULGARIS 1 ARTEMISIA VULGARIS POLLEN EXTRACT 1 ASPERGILLUS FUMIGATUS 1 CAT EPITHELIA 1 CORYLUS AVELLANA L., ALNUS GLUTINOSA POLLEN, BETULA VERRUCOSA POLLEN 1 DERMATOPHAGOIDES FARINAE 1 DERMATOPHAGOIDES PTERONYSSINUS 1 DERMATOPHAGOIDES PTERONYSSINUS, DERMATOPHAGOIDES FARINAE 1 DOG EPITHELIA 1 HISTAMINE DIHYDROCHLORIDE 1 PHENOL, LIQUEFIED 1 PHLEUM PRATENSE, DACTYLIS GLOMERATA, ANTHOXANTHUM ODORATUM, LOLIUM PERENNE, POA PRATENSIS, SECALE CEREALE, ARRHENATHERUM ELATIUS, AGROSTIS STOLONIFERA POLLEN, FESTUCA RUBRA POLLEN, HOLCUS LANATUS POLLEN EXTRACT 1

All trials

1 total

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutane… Ended

2023-504942-75-01 Phase III 6 countries ARTEMISIA VULGARIS; ARTEMISIA VULGARIS POLLEN EXTRACT; ASPERGILLUS FUMIGATUS; CA…

Showing 1–1 of 1 trials

← All sponsors A–Z